Currently predicting for Mon, 1 Apr 2024

ACRX Predictions History

3 years ago
JS predicted that ACRX for 2021-02-19 is going $2.13 (-1.39%)

3 years ago
Billy Bob predicted that ACRX for 2021-02-19 is going $2.25 (4.17%)

Rank:

3 years ago
Billy Bob predicted that ACRX for 2021-02-11 is going $2.90 (10.27%)

Rank:

3 years ago
JS predicted that ACRX for 2021-02-10 is going $2.67 (1.14%)

3 years ago
Eduardo Rodriguez predicted that ACRX for 2021-02-10 is going

Rank:

3 years ago
JS predicted that ACRX for 2021-01-22 is going $1.93 (1.05%)

3 years ago
steve mayfield predicted that ACRX for 2021-01-22 is going $1.91 (0.00%)

Rank:

3 years ago
JS predicted that ACRX for 2021-01-20 is going $2.21 (13.33%)

3 years ago
steve mayfield predicted that ACRX for 2021-01-20 is going $2.70 (38.46%)

Rank:

3 years ago
JS predicted that ACRX for 2021-01-19 is going $2.10 (0.96%)

Click to get the best stock tips daily for free!

About AcelRx Pharmaceuticals

AcelRx Pharmaceuticals AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pai... ACRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT